{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:50Z","timestamp":1791704810222,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473215"],"award-info":[{"award-number":["82473215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103041","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:55:38Z","timestamp":1790110538000},"page":"103041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CXCL9 drives lung adenocarcinoma progression and immunotherapy response via activation of the CXCR3\/JAK1\/STAT3 signaling pathway"],"prefix":"10.1016","volume":"73","author":[{"given":"Qing","family":"Ju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.tranon.2026.103041_bib0001","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/cancers16071414","article-title":"Real-world data and evidence in lung cancer: a review of recent developments","volume":"16","author":"Kokkotou","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.tranon.2026.103041_bib0002","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/ijmm.2014.1857","article-title":"AP-2\u03b1 downregulation by cigarette smoke condensate is counteracted by p53 in human lung cancer cells","volume":"34","author":"Meng","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.tranon.2026.103041_bib0003","article-title":"Uniqueness of lung cancer in Southeast Asia","volume":"27","author":"Noronha","year":"2024","journal-title":"Lancet Reg. Health Southeast Asia"},{"key":"10.1016\/j.tranon.2026.103041_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1285274","article-title":"A two-sample mendelian randomization analysis: causal association between chemokines and pan-carcinoma","volume":"14","author":"Cui","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.tranon.2026.103041_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155219","article-title":"Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death","volume":"123","author":"Hu","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0006","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13008-024-00112-2","article-title":"Anti-cancer effects of Coix seed extract through KCTD9-mediated ubiquitination of TOP2A in lung adenocarcinoma","volume":"19","author":"Jiang","year":"2024","journal-title":"Cell Div."},{"key":"10.1016\/j.tranon.2026.103041_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1683585","article-title":"CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agent","volume":"16","author":"Ramalingam","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tranon.2026.103041_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107351","article-title":"Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer","volume":"184","author":"Murata","year":"2023","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45284-z","article-title":"SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma","volume":"13","author":"Shan","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.tranon.2026.103041_bib0010","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.3390\/cancers15112937","article-title":"Autotaxin inhibition with IOA-289 decreases breast tumor growth in mice whereas knockout of Autotaxin in adipocytes does not","volume":"15","author":"Tang","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0011","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2279800","article-title":"Tumor-intrinsic RGS1 potentiates checkpoint blockade response via ATF3-IFNGR1 axis","volume":"12","author":"Wang","year":"2023","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.tranon.2026.103041_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14489","article-title":"A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response","volume":"30","author":"Duan","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"11","key":"10.1016\/j.tranon.2026.103041_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241241","article-title":"Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: a meta-analysis","volume":"15","author":"Wang","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.tranon.2026.103041_bib0014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-030-36667-4_5","article-title":"The multifaceted roles of CXCL9 within the tumor microenvironment","volume":"1231","author":"Neo","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.tranon.2026.103041_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00262-026-04456-2","article-title":"CXCL9\/SPP1-polarized tumor-associated macrophages exert dual roles in regulating anti-tumor immunity in lung adenocarcinoma","volume":"75","author":"Liu","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/wvn.70103","article-title":"Comparative efficacy of e-health interventions for quality of life in patients with cancer: a network meta-analysis of randomized controlled trials","volume":"23","author":"Duan","year":"2026","journal-title":"Worldviews Evid.-Based Nurs."},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/pon.70377","article-title":"The effectiveness of telemedicine-based psychosocial intervention for fear of cancer recurrence, mindfulness, and posttraumatic growth in cancer survivors: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Su","year":"2026","journal-title":"Psychooncology"},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0018","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1158\/0008-5472.226.65.1","article-title":"Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer","volume":"65","author":"Amann","year":"2005","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.tranon.2026.103041_bib0019","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1158\/1078-0432.CCR-20-2077","article-title":"Epithelial-to-mesenchymal transition is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C-mutant non-small cell lung cancer","volume":"26","author":"Adachi","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.tranon.2026.103041_bib0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41419-023-06354-2","article-title":"The duality of CXCR3 in glioblastoma: unveiling autocrine and paracrine mechanisms for novel therapeutic approaches","volume":"14","author":"Chan","year":"2023","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.tranon.2026.103041_bib0021","article-title":"CXCL9\/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer","volume":"5","author":"Lim","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"12","key":"10.1016\/j.tranon.2026.103041_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114127","article-title":"CCL19-armed recombinant influenza virus inhibited colorectal cancer growth by remodeling tumor microenvironment","volume":"28","author":"Ou","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.tranon.2026.103041_bib0023","doi-asserted-by":"crossref","unstructured":"You Y., Sarkar S., Deiter C., Elliott E.C., Nicora C.D., Mirmira R.G., et al. Reduction of chemokine CXCL9 expression by omega-3 fatty acids via ADP-ribosylhydrolase ARH3 in MIN6 insulin-producing cells. bioRxiv. 2024.","DOI":"10.1101\/2024.01.30.578079"},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0024","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70832-6","article-title":"Weighted gene co-expression network analysis identified GBP2 connected to PPARalpha activity and liver cancer","volume":"14","author":"AmeliMojarad","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12931-025-03251-4","article-title":"Low levels of DNA repair enzyme NEIL2 May exacerbate inflammation and genomic damage in subjects with stable COPD and during severe exacerbations","volume":"26","author":"Cardenas","year":"2025","journal-title":"Respir Res."},{"issue":"9","key":"10.1016\/j.tranon.2026.103041_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009111","article-title":"Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8 (+) T cell infiltration","volume":"12","author":"Gan","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"16","key":"10.1016\/j.tranon.2026.103041_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36598","article-title":"T lymphocyte-derived IFN-gamma facilitates breast cancer cells to pass the blood-brain barrier: an in vitro study corroborating translational data","volume":"10","author":"Pedrosa","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.tranon.2026.103041_bib0028","unstructured":"Ranti D., Yu H., Wang Y.A., Bieber C., Strandgaard T., Salome B., et al. HLA-E and NKG2A mediate resistance to M. bovis BCG Immunotherapy in non-muscle-invasive bladder cancer. bioRxiv. 2024."},{"key":"10.1016\/j.tranon.2026.103041_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117401","article-title":"Astragalus polysaccharide enhances antitumoral effects of chimeric antigen receptor- engineered (CAR) T cells by increasing CD122 (+)CXCR3 (+)PD-1 (-) memory T cells","volume":"179","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.tranon.2026.103041_bib0030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13886","article-title":"CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes","volume":"30","author":"Ning","year":"2023","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.tranon.2026.103041_bib0031","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00204-025-04198-7","article-title":"piR-16404 drives ferroptotic liver injury via CASTOR1\/mTORC1\/GPX4 dysregulation in HepG2 cells and mice: a novel toxicity mechanism of N, N-dimethylformamide","volume":"100","author":"Ma","year":"2026","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103041_bib0032","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1039\/D2MO00261B","article-title":"Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer","volume":"19","author":"Wang","year":"2023","journal-title":"Mol. Omics"},{"key":"10.1016\/j.tranon.2026.103041_bib0033","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.tranon.2026.103041_bib0034","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-05-0784","article-title":"Toll-like receptors on tumor cells facilitate evasion of immune surveillance","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.tranon.2026.103041_bib0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1078-0432.CCR-21-1411","article-title":"Intralesional SD-101 in combination with Pembrolizumab in anti-PD-1 treatment-naive head and neck squamous cell carcinoma: results from a multicenter, phase II trial","volume":"28","author":"Cohen","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.103041_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112478","article-title":"A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancer","volume":"137","author":"Zuo","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tranon.2026.103041_bib0037","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2015.12.021","article-title":"The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients","volume":"78","author":"Wu","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.tranon.2026.103041_bib0038","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/carcin\/bgab075","article-title":"JAK\/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance","volume":"42","author":"Sabaawy","year":"2021","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.tranon.2026.103041_bib0039","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/1535-7163.MCT-10-0502","article-title":"JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling","volume":"10","author":"Song","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2026.103041_bib0040","doi-asserted-by":"crossref","unstructured":"Soldevila G., Garc\u00eda-Zepeda E.A. The role of the Jak-Stat pathway in chemokine-mediated signaling in T lymphocytes. 2007;7 (5\u20136):427\u201338.","DOI":"10.1002\/sita.200700144"},{"key":"10.1016\/j.tranon.2026.103041_bib0041","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jare.2024.08.029","article-title":"New insights into the function and mechanisms of piRNA PMLCPIR in promoting PM (2.5)-induced lung cancer","volume":"73","author":"Xu","year":"2025","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103041_bib0042","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13578-020-00521-0","article-title":"BIRC3 and BIRC5: multi-faceted inhibitors in cancer","volume":"11","author":"Frazzi","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tranon.2026.103041_bib0043","doi-asserted-by":"crossref","unstructured":"Yadav A., Kumar B., Datta J., Teknos T., Kumar P.J.M.cr.M.. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. 2011;9:1658\u201367.","DOI":"10.1158\/1541-7786.MCR-11-0271"},{"issue":"4","key":"10.1016\/j.tranon.2026.103041_bib0044","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10585-012-9545-6","article-title":"CCL2 is critical for immunosuppression to promote cancer metastasis","volume":"30","author":"Kudo-Saito","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.tranon.2026.103041_bib0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/stem.1281","article-title":"Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR\/Stat3\/Sox-2 signaling pathway","volume":"31","author":"Yang","year":"2013","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.tranon.2026.103041_bib0046","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bcp.2011.12.024","article-title":"The many faces of Janus kinase","volume":"83","author":"Seavey","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tranon.2026.103041_bib0047","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.intimp.2017.11.032","article-title":"Repression of interferon \u03b2-regulated cytokines by the JAK1\/2 inhibitor ruxolitinib in inflammatory human macrophages","volume":"54","author":"Febvre-James","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tranon.2026.103041_bib0048","doi-asserted-by":"crossref","unstructured":"Owen K.L., Brockwell N.K., Parker B.S. JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression. 2019;11 (12):2002.","DOI":"10.3390\/cancers11122002"},{"issue":"11","key":"10.1016\/j.tranon.2026.103041_bib0049","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1016\/j.apsb.2025.08.003","article-title":"Arsenic trioxide-based nanoparticles for enhanced chemotherapy by activating pyroptosis","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"Pt 1","key":"10.1016\/j.tranon.2026.103041_bib0050","article-title":"A novel GSH depletor for simultaneous ferroptosis and cuproptosis activation in hepatocellular carcinoma","volume":"243","author":"Yang","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tranon.2026.103041_bib0051","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation \u2013 a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.tranon.2026.103041_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113793","article-title":"CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity","volume":"43","author":"House","year":"2024","journal-title":"Cell Rep."},{"issue":"Pt 2","key":"10.1016\/j.tranon.2026.103041_bib0053","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj20030842","article-title":"Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines","volume":"376","author":"Hiroi","year":"2003","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.tranon.2026.103041_bib0054","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s13205-025-04586-x","article-title":"Expression and prognosis of mPR\u03b1\/PAQR7 in human cancers and validation in lung squamous cell carcinoma","volume":"15","author":"Xiao","year":"2025","journal-title":"3 Biotech"},{"issue":"5","key":"10.1016\/j.tranon.2026.103041_bib0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.clbc.2025.03.006","article-title":"Harnessing artificial intelligence for precision diagnosis and treatment of triple negative breast cancer","volume":"25","author":"Hussain","year":"2025","journal-title":"Clin. Breast Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.103041_bib0056","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006939","article-title":"Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy","volume":"11","author":"Yin","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2026.103041_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003534","article-title":"Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma","volume":"10","author":"Yang","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tranon.2026.103041_bib0058","article-title":"Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:30:16Z","timestamp":1791703816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":58,"alternative-id":["S1936523326003773"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103041","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL9 drives lung adenocarcinoma progression and immunotherapy response via activation of the CXCR3\/JAK1\/STAT3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103041"}}